Target intelligence / Profile preview

Transforming Growth Factor, Beta Receptor II (TGFBR2)

Target: TGFBR2
Molecular classification: Receptor, Serine/threonine kinase

Overview

The Transforming Growth Factor, Beta Receptor II (TGFBR2) is a transmembrane serine/threonine kinase receptor that plays a crucial role in the TGF-beta signaling pathway. It forms a heterodimeric complex with TGF-beta receptor type I (TGFBR1) to transduce signals from TGF-beta ligands, influencing cell proliferation, differentiation, and other physiological processes. Mutations in the TGFBR2 gene are associated with several diseases, including Marfan syndrome and Loeys-Dietz syndrome. TGFBR2 acts as a tumor suppressor and is involved in both canonical SMAD-dependent and non-canonical SMAD-independent signaling pathways.

Other names: TGF-beta type II receptorTbetaR-IITGFR-2

Mechanism of action

Inhibition or modulation of TGF-beta signaling pathways, which can affect cell proliferation, differentiation, and other biological processes.

Biological functions

Signal transductionCell proliferationCell differentiationWound healingExtracellular matrix productionImmunosuppression

Disease associations

CancerCardiovascular disease (e.g., Marfan syndrome, Loeys-Dietz syndrome)Neurodegenerative diseases (involvement in brain development)

Safety considerations

Potential for disrupting normal TGF-beta signaling, which could lead to unintended effects on cell growth and differentiation.

Biomarkers

Mutations in the TGFBR2 gene can serve as biomarkers for certain diseases like Marfan syndrome and Loeys-Dietz syndrome.

Beyond the preview

Go deeper on Transforming Growth Factor, Beta Receptor II (TGFBR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transforming Growth Factor, Beta Receptor II (TGFBR2).

Explore the full profile